Back
Zealand Pharma AS Quote, Financials, Valuation and Earnings
Sponsored
ZLDPF
Sponsored
Multimillionaire Trader Reveals His #1 Gold Pick
Click here to learn more about this game-changing opportunity.
Sell
44
ZLDPF
Zealand Pharma AS
Last Price:
114.33
Seasonality Move:
-1.7%
7 Day Trial
ALL ACCESS PASS
$
7
7 Proven Winners to Buy and Hold Forever
More Details here...Zealand Pharma AS Price Quote
$114.33
+2.33 (+2.08%)
(Updated: October 17, 2024 at 6:55 PM ET)
Zealand Pharma AS Key Stats
Sell
44
Zealand Pharma AS (ZLDPF)
is a Sell
Day range:
$111.78 - $112.00
52-week range:
$40.40 - $141.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
129.51
P/B ratio:
6.01%
Volume:
3.1K
Avg. volume:
985
1-year change:
153.51%
Market cap:
$8.1B
Revenue:
$49.8M
EPS:
$-1.7
How Much Does Zealand Pharma AS Make?
-
How Much Are Zealand Pharma AS's Sales Annually?
ZLDPF Revenues are $49.8M -
How Much Profit Does Zealand Pharma AS's Make A Year?
ZLDPF net income is -$102.2M
Is Zealand Pharma AS Growing As A Company?
-
What Is Zealand Pharma AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is 2.24% -
What Is Zealand Pharma AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Zealand Pharma AS Stock Price Performance
-
Did Zealand Pharma AS Stock Go Up Last Month?
Zealand Pharma AS share price went down by -16.86% last month -
Did ZLDPF's Share Price Rise Over The Last Year?
ZLDPF share price rose by 153.51% over the past 1 year
What Is Zealand Pharma AS 52-Week High & Low?
-
What Is Zealand Pharma AS’s 52-Week High Share Price?
Zealand Pharma AS has traded as high as $141.74 over the past 52 weeks -
What Is Zealand Pharma AS’s 52-Week Low Share Price?
Zealand Pharma AS has traded as low as $40.40 over the past 52 weeks
Zealand Pharma AS Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Zealand Pharma AS?
-
How Much Debt Does Zealand Pharma AS Have?
Total long term debt quarterly is $39.7M -
How Much Cash Does Zealand Pharma AS Have?
Cash and short term investments quarterly total is $1.3B -
What Is Zealand Pharma AS’s Book Value Per Share?
Book value per share is 19.02
Is Zealand Pharma AS Cash Flow Positive?
-
What Is ZLDPF Cash Flow From Operations?
Cash flow from operations (TTM) is -$73M -
What Is Zealand Pharma AS’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2B -
What Is Zealand Pharma AS’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$177.9M
Zealand Pharma AS Return On Invested Capital
-
Is Management Doing A Good Job?
ZLDPF return on invested capital is -19.92% -
What Is Zealand Pharma AS Return On Assets?
ROA measures how assets are converting to revenues and is -17.89% -
What Is ZLDPF Return On Equity?
ROE is a measure of profitability and is -20.55%
Zealand Pharma AS Earnings Date & Stock Price
-
What Is Zealand Pharma AS's Stock Price Today?
A single share of ZLDPF can be purchased today for 112.00 -
What Is Zealand Pharma AS’s Stock Symbol?
Zealand Pharma AS trades on the otcm under the ticker symbol: ZLDPF -
When Is Zealand Pharma AS’s Next Earnings Date?
The next quarterly earnings date for Zealand Pharma AS is scheduled on November 7, 2024 -
When Is ZLDPF's next ex-dividend date?
Zealand Pharma AS's next ex-dividend date is October 18, 2024 -
How To Buy Zealand Pharma AS Stock?
You can buy Zealand Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Zealand Pharma AS Competitors
-
Who Are Zealand Pharma AS's Competitors?
Below is a list of companies who compete with Zealand Pharma AS or are related in some way:
Zealand Pharma AS Dividend Yield
-
What Is ZLDPF Dividend Yield?
Zealand Pharma AS’s dividend yield currently is 0% -
What Is Zealand Pharma AS’s Payout Ratio?
Zealand Pharma AS’s payout ratio is 0% -
When Did Zealand Pharma AS Last Pay A Dividend?
The latest dividend pay date is October 18, 2024 -
What Is Zealand Pharma AS’s Dividend Per Share?
Zealand Pharma AS pays a dividend of $0.00 per share
Zealand Pharma AS Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 223.9% | 277.75% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 22.50 |
Downside from Last Price: | -79.91% |